{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:32:18Z","timestamp":1784892738003,"version":"3.55.0"},"reference-count":32,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Prothrombotic conditions are associated with ischemic stroke in young women. In particular, the combination of oral contraceptive use and prothrombotic genetic variants appears to increase the risk of ischemic stroke. We performed a population-based case-control study in 190 women aged 20 to 49 years with ischemic stroke and 767 women without cardiovascular disease stratified for age, calendar year of the index event, and residence. A total of 4 variants of coagulation factor XIII subunit A and B genes (F13A1 and F13B) were investigated. The Phe allele of the F13A1 Tyr204Phe variant was present in 59 (31%) patients and 43 (6%) controls; the odds ratio for ischemic stroke was 9.1 for Phe\/Phe and Phe\/Tyr versus Tyr\/Tyr genotype; the 95% confidence interval was 5.5 to 15. Homozygous genotypes (Phe\/Phe) conferred a higher risk (odds ratio, 77; 95% confidence interval, 7.0-848) than heterozygous (Tyr\/Phe) genotypes (odds ratio, 8.2; 95% confidence interval, 4.9-14). The risk of ischemic stroke was further increased in carriers of the 204Phe allele using oral contraceptives (odds ratio, 20; 95% confidence interval, 9-46) compared with nonusers with Tyr\/Tyr genotype. In conclusion, the F13A1 204Phe allele was strongly associated with ischemic stroke in young women. Oral contraceptive use further increased the risk of ischemic stroke.<\/jats:p>","DOI":"10.1182\/blood-2007-08-110254","type":"journal-article","created":{"date-parts":[[2007,11,16]],"date-time":"2007-11-16T01:54:25Z","timestamp":1195178065000},"page":"1282-1286","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":55,"title":["Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke"],"prefix":"10.1182","volume":"111","author":[{"given":"D. Martijn O.","family":"Pruissen","sequence":"first","affiliation":[{"name":"Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjen J. C.","family":"Slooter","sequence":"additional","affiliation":[{"name":"Department of Intensive Care, University Medical Center Utrecht, Utrecht;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits R.","family":"Rosendaal","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Leiden University Medical Center, Leiden;"},{"name":"Department of Thrombosis and Hemostasis and Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"van der Graaf","sequence":"additional","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ale","family":"Algra","sequence":"additional","affiliation":[{"name":"Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht;"},{"name":"Department of Clinical Epidemiology, Leiden University Medical Center, Leiden;"},{"name":"Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111720555274800_B1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.284.1.72","article-title":"Ischemic stroke risk with oral contraceptives: a meta-analysis.","volume":"284","author":"Gillum","year":"2000","journal-title":"JAMA"},{"key":"2019111720555274800_B2","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/gepi.20171","article-title":"Familial aggregation of ischemic stroke in young women: the Stroke Prevention in Young Women Study.","volume":"30","author":"MacClellan","year":"2006","journal-title":"Genet Epidemiol"},{"key":"2019111720555274800_B3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/jnnp.2006.101675","article-title":"Inherited thrombophilia and stratification of ischaemic stroke risk among users of oral contraceptives.","volume":"78","author":"Pezzini","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2019111720555274800_B4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1160\/TH03-11-0690","article-title":"Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke.","volume":"91","author":"Aznar","year":"2004","journal-title":"Thromb Haemost"},{"key":"2019111720555274800_B5","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1538-7836.2005.01442.x","article-title":"Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke.","volume":"3","author":"Slooter","year":"2005","journal-title":"J Thromb Haemost"},{"key":"2019111720555274800_B6","first-page":"844","article-title":"Oral contraceptive use, thrombophilia and their interaction in young women with ischemic stroke.","volume":"91","author":"Martinelli","year":"2006","journal-title":"Haematologica"},{"key":"2019111720555274800_B7","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1161\/01.ATV.0000136649.83297.bf","article-title":"Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease.","volume":"24","author":"Scott","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019111720555274800_B8","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0140-6736(03)13135-2","article-title":"Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk.","volume":"361","author":"Lim","year":"2003","journal-title":"Lancet"},{"key":"2019111720555274800_B9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bpc.2004.07.023","article-title":"FXIII polymorphisms, fibrin clot structure and thrombotic risk.","volume":"112","author":"Kobbervig","year":"2004","journal-title":"Biophys Chem"},{"key":"2019111720555274800_B10","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1182\/blood-2003-07-2247","article-title":"Genetics of fibrin clot structure: a twin study.","volume":"103","author":"Dunn","year":"2004","journal-title":"Blood"},{"key":"2019111720555274800_B11","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1182\/blood.V96.3.988","article-title":"The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure.","volume":"96","author":"Ariens","year":"2000","journal-title":"Blood"},{"key":"2019111720555274800_B12","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1160\/TH06-09-0517","article-title":"Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis.","volume":"97","author":"Shafey","year":"2007","journal-title":"Thromb Haemost"},{"key":"2019111720555274800_B13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1182\/blood.V95.2.586","article-title":"The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction.","volume":"95","author":"Elbaz","year":"2000","journal-title":"Blood"},{"key":"2019111720555274800_B14","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1055\/s-0037-1614399","article-title":"The Leu564 factor XIIIA variant results in significantly lower plasma factor XIII levels than the Pro564 variant.","volume":"82","author":"Gallivan","year":"1999","journal-title":"Thromb Haemost"},{"key":"2019111720555274800_B15","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1182\/blood.V93.3.897","article-title":"Genotype\/phenotype correlations for coagulation factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity.","volume":"93","author":"Anwar","year":"1999","journal-title":"Blood"},{"key":"2019111720555274800_B16","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1365-2141.2002.03265.x","article-title":"Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women.","volume":"116","author":"Reiner","year":"2002","journal-title":"Br J Haematol"},{"key":"2019111720555274800_B17","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1111\/j.1538-7836.2005.01624.x","article-title":"A novel polymorphism in the factor XIII B-subunit (His95Arg): relationship to subunit dissociation and venous thrombosis.","volume":"3","author":"Komanasin","year":"2005","journal-title":"J Thromb Haemost"},{"key":"2019111720555274800_B18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1182\/blood-2002-07-2308","article-title":"Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction.","volume":"102","author":"Reiner","year":"2003","journal-title":"Blood"},{"key":"2019111720555274800_B19","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1016\/S0002-9378(99)70698-8","article-title":"Hemostatic effects of smoking and oral contraceptive use.","volume":"180","author":"Fruzzetti","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"2019111720555274800_B20","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.STR.0000015345.61324.3F","article-title":"Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke.","volume":"33","author":"Kemmeren","year":"2002","journal-title":"Stroke"},{"key":"2019111720555274800_B21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1050-3862(98)00019-9","article-title":"Allelic discrimination using fluorogenic probes and the 5\u2032 nuclease assay.","volume":"14","author":"Livak","year":"1999","journal-title":"Genet Anal"},{"key":"2019111720555274800_B22","unstructured":"National Center for Biotechnology Information\n          Single nucleotide polymorphism database.\n          Accessed July 6, 2007\n          Available at: http:\/\/www.ncbi.nlm.nih.gov\/projects\/SNP"},{"key":"2019111720555274800_B23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(03)12715-8","article-title":"Problems of reporting genetic associations with complex outcomes.","volume":"361","author":"Colhoun","year":"2003","journal-title":"Lancet"},{"key":"2019111720555274800_B24","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1161\/01.STR.0000081224.15480.52","article-title":"Are changes in mortality from stroke caused by changes in stroke event rates or case fatality? Results from the WHO MONICA Project.","volume":"34","author":"Sarti","year":"2003","journal-title":"Stroke"},{"key":"2019111720555274800_B25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.maturitas.2003.08.006","article-title":"Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project.","volume":"48","author":"Lundberg","year":"2004","journal-title":"Maturitas"},{"key":"2019111720555274800_B26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0010-7824(97)00172-8","article-title":"Reproducibility of oral contraceptive histories and validity of hormone composition reported in a cohort of US women.","volume":"56","author":"Hunter","year":"1997","journal-title":"Contraception"},{"key":"2019111720555274800_B27","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1371\/journal.pmed.0040131","article-title":"Genetics of ischaemic stroke among persons of non-European descent: a meta-analysis of eight genes involving approximately 32,500 individuals.","volume":"4","author":"Ariyaratnam","year":"2007","journal-title":"PLOS Med"},{"key":"2019111720555274800_B28","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMcp030751","article-title":"Clinical practice: combination estrogen-progestin oral contraceptives.","volume":"349","author":"Petitti","year":"2003","journal-title":"N Engl J Med"},{"key":"2019111720555274800_B29","first-page":"35","article-title":"Incidence of cerebrovascular disease in The Netherlands in 2000.","volume-title":"Cardiovascular disease in The Netherlands 2006","author":"Bots","year":"2006"},{"key":"2019111720555274800_B30","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/1097-0215(20011120)95:6<370::AID-IJC1065>3.0.CO;2-T","article-title":"Low-dose oral contraceptives: protective effect on ovarian cancer risk.","volume":"95","author":"Royar","year":"2001","journal-title":"Int J Cancer"},{"key":"2019111720555274800_B31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00003081-200103000-00010","article-title":"Oral contraceptives: current status.","volume":"44","author":"Burkman","year":"2001","journal-title":"Clin Obstet Gynecol"},{"key":"2019111720555274800_B32","article-title":"World Health Report 2005: Make Every Mother and Child Count.","author":"World Health Organization","year":"2005"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/3\/1282\/1305654\/zh800308001282.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/3\/1282\/1305654\/zh800308001282.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T01:56:07Z","timestamp":1574042167000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/111\/3\/1282\/25428\/Coagulation-factor-XIII-gene-variation-oral"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,1]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,2,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2007-08-110254","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,1]]}}}